Target
Fibroblast growth factor receptor 4
Ligand
BDBM209329
Substrate
n/a
Meas. Tech.
ChEMBL_2068042 (CHEMBL4723295)
IC50
17±n/a nM
Citation
 Fairhurst, RAKnoepfel, TBuschmann, NLeblanc, CMah, RTodorov, MNimsgern, PRipoche, SNiklaus, MWarin, NLuu, VHMadoerin, MWirth, JGraus-Porta, DWeiss, AKiffe, MWartmann, MKinyamu-Akunda, JSterker, DStamm, CAdler, FBuhles, ASchadt, HCouttet, PBlank, JGaluba, ITrappe, JVoshol, JOstermann, NZou, CBerghausen, JDel Rio Espinola, AJahnke, WFuret, P Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4. J Med Chem 63:12542-12573 (2020) [PubMed]  Article 
Target
Name:
Fibroblast growth factor receptor 4
Synonyms:
CD_antigen=CD334 | FGFR4_MOUSE | Fgfr-4 | Fgfr4 | Fibroblast growth factor receptor | Fibroblast growth factor receptor 4 | Mpk-11 | Protein-tyrosine kinase receptor MPK-11
Type:
PROTEIN
Mol. Mass.:
88660.29
Organism:
Mus musculus
Description:
ChEMBL_820929
Residue:
799
Sequence:
MWLLLALLSIFQGTPALSLEASEEMEQEPCLAPILEQQEQVLTVALGQPVRLCCGRTERGRHWYKEGSRLASAGRVRGWRGRLEIASFLPEDAGRYLCLARGSMTVVHNLTLLMDDSLTSISNDEDPKTLSSSSSGHVYPQQAPYWTHPQRMEKKLHAVPAGNTVKFRCPAAGNPMPTIHWLKDGQAFHGENRIGGIRLRHQHWSLVMESVVPSDRGTYTCLVENSLGSIRYSYLLDVLERSPHRPILQAGLPANTTAVVGSDVELLCKVYSDAQPHIQWLKHVVINGSSFGADGFPYVQVLKTTDINSSEVEVLYLRNVSAEDAGEYTCLAGNSIGLSYQSAWLTVLPEEDLTWTTATPEARYTDIILYVSGSLVLLVLLLLAGVYHRQVIRGHYSRQPVTIQKLSRFPLARQFSLESRSSGKSSLSLVRGVRLSSSGPPLLTGLVNLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPSRPDQTSTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPALVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDDVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFEILLWEIFTLGGSPYPGIPVEELFSLLREGHRMERPPNCPSELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEEYLDLRLTFGPFSPSNGDASSTCSSSDSVFSHDPLPLEPSPFPFSDSQTT
  
Inhibitor
Name:
BDBM209329
Synonyms:
US9266883, 87
Type:
Small organic molecule
Emp. Form.:
C23H29N7O4
Mol. Mass.:
467.5209
SMILES:
CN(C)CC(C)(O)CNc1cc(NC(=O)N2CCCc3cc(CO)c(C=O)nc23)ncc1C#N
Structure:
Search PDB for entries with ligand similarity: